Patent details

300751 Product Name: Secukinumab.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300751
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1641822
Status:
Withdrawn
Application number:
300751
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/14/980
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/01/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
15/07/2015
First Marketing Authorization date:
15/01/2015
Grant date:
Activation date:
02/06/2024
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
15/07/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
20/04/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/07/2015
 
 

 

Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
15/07/2015
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Contains data concerning lapse or annulment

2

Bulletin Heading:
VRV
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Contains data concerning lapse or annulment

3

Bulletin Heading:
SPC
Journal edition number:
2015/31
Publication date:
29/07/2015
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Filing date Document type Document Description Number of pages
21/04/2020 Outgoing Correspondence Letter confirmation withdrawal 1 /1/5/7/0/0/0400300751/docs/300751_2_340059l193.pdf
06/03/2019 Outgoing Correspondence Letter communication third party to holder 1 /1/5/7/0/0/0400300751/docs/300751_0_257682l035.pdf
06/03/2019 Outgoing Correspondence Letter communication third party to holder 1 /1/5/7/0/0/0400300751/docs/300751_5_257678l035.pdf
21/02/2019 Incoming Correspondence Paper Incoming Correspondence Paper 2 /1/5/7/0/0/0400300751/docs/300751_3_incomingcorrespondencepaper20190225085040730.pdf
21/01/2016 Outgoing Correspondence Letter to applicant 1 /1/5/7/0/0/0400300751/docs/300751_8_outgoingcorrespondence20200330031404387.pdf
09/10/2015 Incoming Correspondence Paper Accompanying letter incoming document 1 /1/5/7/0/0/0400300751/docs/300751_4_incomingcorrespondencepaper20151020040716206.pdf
11/08/2015 Outgoing Correspondence Outgoing Letter 3 /1/5/7/0/0/0400300751/docs/300751_10_outgoingcorrespondence20150812.pdf
17/07/2015 Outgoing Correspondence Outgoing Letter 1 /1/5/7/0/0/0400300751/docs/300751_6_outgoingcorrespondence20150717.pdf
16/07/2015 SPC Documents Marketing Authorization SPC 3 /1/5/7/0/0/0400300751/docs/300751_1_supplprotectioncertificate20200330033730466.pdf
16/07/2015 Application Form First filed application form 3 /1/5/7/0/0/0400300751/docs/300751_7_applicationform20150716.pdf
16/07/2015 SPC Documents Summary of the characteristics of the product 84 /1/5/7/0/0/0400300751/docs/300751_9_supplprotectioncertificate20200330032743120.pdf